Pharmacyte Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.42

-0.02 (-4.78%)

As of Sep 28, 10:43 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +6,504.0% upside

Low Target $20.43

Average Target $27.73

High Target $35.07

Current Price $0.42

Current
$0.42

Target
$27.73

$20.43 $27.73 avg $35.07

Scenario Analysis

Bear Case

$20.43

4,765.4%

Low target

Base Case

$27.73

+6,504.0%

Avg target

Bull Case

$35.07

+8,252.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.51

-72.2% from high

52-Week Low

$0.33

+25.8% from low

Target vs 52W High

$27.73

+1,736.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%